Literature DB >> 2149966

Prevalence of dementia in adult patients with trisomy 21.

M Franceschi1, M Comola, F Piattoni, W Gualandri, N Canal.   

Abstract

Neuropathological lesions characteristic of Alzheimer's disease (AD) are found in all the brains of patients with trisomy 21 who die after age 40 years. However, clinical signs of AD are much less frequent in these patients. Previous studies indicate prevalence figures ranging from 15% to 51% of adult patients. We report here on the prevalence rate of dementia in a population of adult patients with trisomy 21 with mild retardation living at home. For all these patients accurate and reliable anamnestic data could be obtained from parents and caregivers. All underwent neurological examination, cognitive testing, and, if necessary, further bioimaging and neurophysiological studies. Dementia was diagnosed according to clinical NINCDS/ADRDA criteria slightly modified. Dementia was found in 9 of 50 (18%) patients age 20-52 years, but its prevalence increased from 0 in the age group 20-29, to 33% in the age group 30-39, and to 55% in the age group 40-52. All the demented patients had signs of brain atrophy on CT scans and slow EEGs. Dementia is an important problem for patients with trisomy 21 older than age 30 years.

Entities:  

Mesh:

Year:  1990        PMID: 2149966     DOI: 10.1002/ajmg.1320370760

Source DB:  PubMed          Journal:  Am J Med Genet Suppl        ISSN: 1040-3787


  5 in total

1.  Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?

Authors:  Troy T Rohn; Katie L McCarty; Julia E Love; Elizabeth Head
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014-12-08

Review 2.  Chromosomal aneuploidy in the aging brain.

Authors:  Francesca Faggioli; Jan Vijg; Cristina Montagna
Journal:  Mech Ageing Dev       Date:  2011-04-28       Impact factor: 5.432

3.  Alzheimer's Disease in Down Syndrome.

Authors:  Elizabeth Head; David Powell; Brian T Gold; Frederick A Schmitt
Journal:  Eur J Neurodegener Dis       Date:  2012-12

Review 4.  Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis.

Authors:  Elizabeth Head; David K Powell; Frederick A Schmitt
Journal:  Front Aging Neurosci       Date:  2018-06-21       Impact factor: 5.750

5.  Parental Age and the Risk for Alzheimer's Disease in Offspring: Systematic Review and Meta-Analysis.

Authors:  Natalia Szejko; Pedro Macul Ferreira de Barros; Victor J Avila-Quintero; Adam Lombroso; Michael Howard Bloch
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2021-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.